SARS-CoV2 infection and clinical disability outcomes in Multiple Sclerosis spectrum disorders: results from a tertiary center in Southern Italy

Authors
Category Primary study
Conference40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, ECTRIMS 2024
Year 2024
This article has no abstract
Epistemonikos ID: 118e0df70d0912de6e230923dcea772b2a0bf000
First added on: Mar 31, 2026